Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Female Contraception Drug Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Female Contraception Drug Market Status and Forecast (2016-2027)
      • 1.3.2 Global Female Contraception Drug Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Female Contraception Drug Supply by Company

    • 2.1 Global Female Contraception Drug Sales Volume by Company
    • 2.2 Global Female Contraception Drug Sales Value by Company
    • 2.3 Global Female Contraception Drug Price by Company
    • 2.4 Female Contraception Drug Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Female Contraception Drug Market Status by Category

    • 3.1 Female Contraception Drug Category Introduction
      • 3.1.1 AG-890
      • 3.1.2 Amphora
      • 3.1.3 BAY-1007626
      • 3.1.4 Drospirenone
      • 3.1.5 Others
    • 3.2 Global Female Contraception Drug Market by Category
      • 3.2.1 Global Female Contraception Drug Sales Volume by Category (2016-2021)
      • 3.2.2 Global Female Contraception Drug Sales Value by Category (2016-2021)
      • 3.2.3 Global Female Contraception Drug Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Female Contraception Drug Market Status by End User/Segment

    • 4.1 Female Contraception Drug Segment by End User/Segment
      • 4.1.1 Clinic
      • 4.1.2 Hospital
      • 4.1.3 Homecare
    • 4.2 Global Female Contraception Drug Market by End User/Segment
      • 4.2.1 Global Female Contraception Drug Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Female Contraception Drug Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Female Contraception Drug Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Female Contraception Drug Market Status by Region

    • 5.1 Global Female Contraception Drug Market by Region
      • 5.1.1 Global Female Contraception Drug Sales Volume by Region
      • 5.1.2 Global Female Contraception Drug Sales Value by Region
    • 5.2 North America Female Contraception Drug Market Status
    • 5.3 Europe Female Contraception Drug Market Status
    • 5.4 Asia Pacific Female Contraception Drug Market Status
    • 5.5 Central & South America Female Contraception Drug Market Status
    • 5.6 Middle East & Africa Female Contraception Drug Market Status

    6 North America Female Contraception Drug Market Status

    • 6.1 North America Female Contraception Drug Market by Country
      • 6.1.1 North America Female Contraception Drug Sales Volume by Country (2016-2021)
      • 6.1.2 North America Female Contraception Drug Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Female Contraception Drug Market Status

    • 7.1 Europe Female Contraception Drug Market by Country
      • 7.1.1 Europe Female Contraception Drug Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Female Contraception Drug Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Female Contraception Drug Market Status

    • 8.1 Asia Pacific Female Contraception Drug Market by Country
      • 8.1.1 Asia Pacific Female Contraception Drug Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Female Contraception Drug Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Female Contraception Drug Market Status

    • 9.1 Central & South America Female Contraception Drug Market by Country
      • 9.1.1 Central & South America Female Contraception Drug Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Female Contraception Drug Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Female Contraception Drug Market Status

    • 10.1 Middle East & Africa Female Contraception Drug Market by Country
      • 10.1.1 Middle East & Africa Female Contraception Drug Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Female Contraception Drug Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Female Contraception Drug Manufacturing Cost Analysis
    • 11.5 Female Contraception Drug Sales Channel and Distributors Analysis
      • 11.5.1 Female Contraception Drug Sales Channel
      • 11.5.2 Female Contraception Drug Distributors
    • 11.6 Female Contraception Drug Downstream Major Buyers

    12 Global Female Contraception Drug Market Forecast by Category and by End User/Segment

    • 12.1 Global Female Contraception Drug Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Female Contraception Drug Forecast by Category
      • 12.2.1 Global Female Contraception Drug Sales Volume Forecast by Category
      • 12.2.2 Global Female Contraception Drug Sales Value Forecast by Category
      • 12.2.3 Global Female Contraception Drug Price Forecast by Category
    • 12.3 Global Female Contraception Drug Forecast by End User/Segment
      • 12.3.1 Global Female Contraception Drug Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Female Contraception Drug Sales Value Forecast by End User/Segment
      • 12.3.3 Global Female Contraception Drug Price Forecast by End User/Segment

    13 Global Female Contraception Drug Market Forecast by Region/Country

    • 13.1 Global Female Contraception Drug Market Forecast by Region (2022-2027)
      • 13.1.1 Global Female Contraception Drug Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Female Contraception Drug Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Viramal Ltd
      • 14.1.1 Company Information
      • 14.1.2 Female Contraception Drug Product Introduction
      • 14.1.3 Viramal Ltd Female Contraception Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Teva Pharmaceutical Industries Ltd
      • 14.2.1 Company Information
      • 14.2.2 Female Contraception Drug Product Introduction
      • 14.2.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Orbis Biosciences Inc
      • 14.3.1 Company Information
      • 14.3.2 Female Contraception Drug Product Introduction
      • 14.3.3 Orbis Biosciences Inc Female Contraception Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Mithra Pharmaceuticals SA
      • 14.4.1 Company Information
      • 14.4.2 Female Contraception Drug Product Introduction
      • 14.4.3 Mithra Pharmaceuticals SA Female Contraception Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Hervana Ltd
      • 14.5.1 Company Information
      • 14.5.2 Female Contraception Drug Product Introduction
      • 14.5.3 Hervana Ltd Female Contraception Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Evofem Inc
      • 14.6.1 Company Information
      • 14.6.2 Female Contraception Drug Product Introduction
      • 14.6.3 Evofem Inc Female Contraception Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Bayer AG
      • 14.7.1 Company Information
      • 14.7.2 Female Contraception Drug Product Introduction
      • 14.7.3 Bayer AG Female Contraception Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Agile Therapeutics Inc
      • 14.8.1 Company Information
      • 14.8.2 Female Contraception Drug Product Introduction
      • 14.8.3 Agile Therapeutics Inc Female Contraception Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Addex Therapeutics Ltd
      • 14.9.1 Company Information
      • 14.9.2 Female Contraception Drug Product Introduction
      • 14.9.3 Addex Therapeutics Ltd Female Contraception Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Female Contraception Drug market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Female Contraception Drug market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      AG-890
      Amphora
      BAY-1007626
      Drospirenone
      Others

      Segmented by End User/Segment
      Clinic
      Hospital
      Homecare

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Viramal Ltd
      Teva Pharmaceutical Industries Ltd
      Orbis Biosciences Inc
      Mithra Pharmaceuticals SA
      Hervana Ltd
      Evofem Inc
      Bayer AG
      Agile Therapeutics Inc
      Addex Therapeutics Ltd
      Buy now